Evidence-based resource helps teens retrain pain signals and responses and supports parents, clinicians, educators, and ...
US FDA places clinical hold on Regenxbio's rare disease program Regenxbio said on Wednesday the U.S. Food and Drug Administration has placed a clinical hold on two of its experimental gene therapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results